Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.24.1.1.u2
Stock-Based Compensation
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
There have been no material changes to the terms of our various equity incentive plans since the filing of our Annual Report on Form 10-K. Refer to Note 13, "Stock-Based Compensation," in our Annual Report on Form 10-K filed with the SEC on March 15, 2024 for more information.
Stock-Based Compensation
Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
Three Months Ended March 31,
Stock-based compensation 2024 2023
Cost of revenues $ 45  $ 253 
Sales and marketing 14  97 
General and administrative 556  859 
Research and development 15  153 
Total stock-based compensation $ 630  $ 1,362 
As of March 31, 2024, there was approximately $1,539 of total unrecognized compensation cost related to our stock benefit plans. These unrecognized compensation costs are expected to be recognized over an estimated weighted-average period of approximately 2.2 years.
Restricted Stock Units
A summary of our restricted stock unit activity for the three months ended March 31, 2024 is set forth below:
Shares Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2023 96,808  $ 25.21 
Granted 9,032  4.13 
Released (27,453) 17.25 
Forfeited —  — 
Outstanding as of March 31, 2024 78,387  $ 25.58 
Stock Options
A summary of our stock option activity under the 2018 Equity Incentive Plan (the "2018 Plan) and related information is as follows:
Number of Shares Weighted Average
Exercise Price		 Weighted Average
Remaining
Contractual Term
(years)		 Aggregate Intrinsic
Value
Outstanding as of December 31, 2023 2,500  $ 56.89  4.2 $ — 
Granted —  — 
Exercised —  — 
Forfeited —  — 
Outstanding as of March 31, 2024 2,500  $ 56.89  3.9 $ — 
Exercisable as of March 31, 2024 2,500  $ 56.89  3.9 $ — 
A summary of our option activity under our 2009 Equity Incentive Plan (the "2019 Plan") and related information is as follows:
Number of Shares Weighted Average
Exercise Price		 Weighted Average
Remaining
Contractual Term
(years)		 Aggregate Intrinsic
Value
Outstanding as of December 31, 2023 14,625  $ 39.67  2.9 $ — 
Granted —  — 
Exercised —  — 
Forfeited (4,114) 44.54 
Outstanding as of March 31, 2024 10,511  $ 37.77  3.8 $ — 
Exercisable as of March 31, 2024 10,511  $ 37.77  3.8 $ — 
Our stock benefit plans had 274,491 and 86,837 shares of common stock reserved for future issuances under our equity incentive plans as of March 31, 2024 and December 31, 2023, respectively. In addition, the shares of common stock reserved for issuance under the 2018 Plan also will include any shares of common stock subject to stock options granted under the 2009 Plan, that expire or otherwise terminate without having been exercised in full and shares of common stock issued pursuant to awards granted under the 2009 Plan that are forfeited. As of March 31, 2024, the maximum number of shares of common stock that may be added to the 2018 Plan pursuant to the foregoing is 10,511.
Furthermore, there were 46,791 and 30,415 shares of common stock available for sale and reserved for issuance under our 2018 Employee Stock Purchase Plan as of March 31, 2024 and December 31, 2023, respectively.